ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Targeting DNA repair in combination with radiotherapy in pancreatic cancer: a systematic review of preclinical studies

Waisse Waissi; Adrien Paix; Anaïs Nicol; Georges Noël; Hélène BurckelUniversité de Strasbourg
Critical Reviews in Oncology/Hematology2020-7-11DOI: 10.1016/j.critrevonc.2020.103060
4阅读
引用收藏
分享

摘要

Background<br/>Current research that combines radiation with targeted therapy may dramatically improve prognosis of pancreatic ductal adenocarcinoma (PDAC). We investigated preclinical outcomes of DNA repair inhibitor targeted therapy associated with radiotherapy.<br/>Methods<br/>We searched Pubmed database to identify publications assessing DNA damage targeted therapies in preclinical models of PDACin vitro and in vivo. Standard enhancement ratio, median survival and growth delay were extracted.<br/>Results<br/>We identified fourteen publications using DNA repair targeted therapies in preclinical models of PDAC. Ten publications comprising twenty-eight experiments evaluated radiosensitization with different DNA repair inhibitors in vitro and displayed cell killing by a factor of 1.35 ± 0.047. Moreover, 86% (24/28) of in vitro experiments showed radiosensitization with DNA damage response inhibitor. However, only 60% (9/15) of the in vivo experiments presented radiosensitization effects.<br/>Conclusion<br/>DNA repair targeted therapies use promising radiosensitizers for PDAC and could successfully be translated into clinical trials.

学科与关键词

关键词
Radiotherapypancreatic cancerinhibitorstargeted therapyDNA repairradiosentization
相关
加载中…
  • DNA damage response and repair in pancreatic cancer development and therapy
    Farnood Parnia Rahnamay; Pazhooh Romina Danesh; Asemi Zatollah; Yousefi BahmanDNA Repair, 2021, prepublish.
  • Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
    Kasun, Wanigasooriya; Robert, Tyler; Joao D., Barros-Silva; Yashashwi, Sinha; Tariq, Ismail; Andrew D., BeggsCancers, 2020, 12(5): 1278.被引 7
  • Pristimerin synergizes with gemcitabine through abrogating Chk1/53BP1-mediated DNA repair in pancreatic cancer cells
    Jiang Zhuangzhuang; Zhao Yang; Zhao Yang; Liu Yanqing; Tao LiFood and Chemical Toxicology, 2021, 147.
查看全部 →

发表信息

论文状态
公开发表
期刊
Critical Reviews in Oncology/Hematology
发表日期
2020-07-11
页码
103060
DOI
10.1016/j.critrevonc.2020.103060
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
SCIENCEDIRECT

作者

  • W

    Waisse Waissi (第一作者)

  • A

    Adrien Paix

查看全部 5 位作者收起作者
  • A

    Anaïs Nicol

  • G

    Georges Noël

  • H

    Hélène Burckel

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417